201 sales jobs found in Covington, GA

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Mayne Pharma is seeking a self-motivated sales professional to drive the adoption of key Women’s Health products through effective relationship building with prescribers.

Mayne Pharma is seeking a self-motivated sales professional to drive the adoption of key Women’s Health products through effective relationship building with prescribers.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

Come join the true partner of global healthcare companies, Amplity Health. We continually challenge the boundaries of medical and commercial strategies to accelerate the approval and launch of new drugs to improve the lives of patients.   Remote Engagement/Hybrid Pharmaceutical Sales Representative   Amplity Health has immediate opportunities.

Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty Pharma division focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.

Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty Pharma division focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty Pharma division focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.